Washington University School of Medicine researchers presented a study linking obesity to an increase in the progression ...

The World Health Organization is now recommending GLP-1 drugs as a tool to manage obesity in adults. The guidance, which says ...

Novo Nordisk submitted a higher-dose version of semaglutide (Wegovy) to the FDA for approval as a weight-management treatment ...

UW Health's Dr. Jeff Pothof discusses guidance from the World Health Organization and United Nations about the use of certain ...

A new study finds preteens who own smartphones and use them regularly, are at greater risk of depression, obesity and ...

Wegovy maker Novo Nordisk is planning to test its experimental obesity drug, CagriSema, in overweight children and ...

Novo Nordisk A/S is planning a large study of its next-generation obesity shot CagriSema in children, a sign the drugmaker is ...

A study found soybean oil contributed to obesity in mice, prompting concern about its use as America's most popular cooking ...

The weight loss medications can be part of a long-term treatment strategy for adults, according to new World Health ...

There are tons of studies that show that what you eat while pregnant can affect your unborn baby, contributing to everything ...

The World Health Organization (WHO) released its first-ever guideline on using GLP-1 medications to treat obesity.

The COVID-19 pandemic not only disrupted children's education, recreation, and social lives, but it also increased the ...